Section Arrow
Quote
TECH.NASDAQ
- Bio-Techne Corp
Quotes are at least 15-min delayed:2025/07/21 06:26 EDT
Pre Market
Last
 51.68
-0.34 (-0.65%)
Bid
46.95
Ask
60.08
High 51.68 
Low 51.68 
Volume 15 
Regular Hours
Last
 52.02
-1.27 (-2.38%)
Day High 
53.89 
Prev. Close
53.29 
1-M High
55.525 
Volume 
1.81M 
Bid
46.95
Ask
60.08
Day Low
51.74 
Open
53.71 
1-M Low
48.41 
Market Cap 
8.35B 
Currency USD 
P/E 62.4 
%Yield 0.62 
10-SMA 52.76 
20-SMA 52.01 
50-SMA 50.41 
52-W High 83.62 
52-W Low 46.01 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
0.83/2.37
Enterprise Value
8.76B
Balance Sheet
Book Value Per Share
12.87
Cash Flow
Cash Flow Yield
0.03
Income Statement
Total Revenue
499.02M
Operating Revenue Per Share
7.30
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
TELOTelomir Pharmaceuticals2.28+1.07+88.43%-- 
Pre Market 2.01 -0.27 -11.84%
SRPTSarepta Therapeutics14.075-7.895-35.94%15.76PE
Pre Market 13.52 -0.555 -3.94%
NCNANuCana plc0.0477+0.0009+1.92%-- 
Pre Market 0.0475 -0.0002 -0.42%
RXRXRecursion Pharmaceuticals5.84+0.32+5.80%-- 
Pre Market 6.15 +0.31 +5.31%
MEIPMEI Pharma5.92+1.42+31.56%1.09PE
Pre Market 6.03 +0.11 +1.86%
Quotes are at least 15-min delayed：2025/07/21 06:26 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of theworld accounting for the remaining 5%.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.